This statistic depicts the market share of biosimilars in Italy in 2017, by type. According to data, concerning G-CSF (Granulocyte-colony stimulating factor), the market share of biosimilar products accounted for 94 percent of the total market, which includes both originators and biosimilars. As regards epoetin, the share of consumption of biosimilars was of 69 percent.
Market share* of biosimilars in Italy in 2017, by type
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
IQVIA. (July 3, 2018). Market share* of biosimilars in Italy in 2017, by type [Graph]. In Statista. Retrieved November 24, 2024, from https://www.statista.com/statistics/877331/market-share-of-biosimilars-by-molecule-in-italy/
IQVIA. "Market share* of biosimilars in Italy in 2017, by type." Chart. July 3, 2018. Statista. Accessed November 24, 2024. https://www.statista.com/statistics/877331/market-share-of-biosimilars-by-molecule-in-italy/
IQVIA. (2018). Market share* of biosimilars in Italy in 2017, by type. Statista. Statista Inc.. Accessed: November 24, 2024. https://www.statista.com/statistics/877331/market-share-of-biosimilars-by-molecule-in-italy/
IQVIA. "Market Share* of Biosimilars in Italy in 2017, by Type." Statista, Statista Inc., 3 Jul 2018, https://www.statista.com/statistics/877331/market-share-of-biosimilars-by-molecule-in-italy/
IQVIA, Market share* of biosimilars in Italy in 2017, by type Statista, https://www.statista.com/statistics/877331/market-share-of-biosimilars-by-molecule-in-italy/ (last visited November 24, 2024)
Market share* of biosimilars in Italy in 2017, by type [Graph], IQVIA, July 3, 2018. [Online]. Available: https://www.statista.com/statistics/877331/market-share-of-biosimilars-by-molecule-in-italy/
